Andrew Peter Turnbull
Président chez Nanolayr Ltd.
Profil
Andrew Peter Turnbull is currently the Chairman of Nanolayr Ltd.
and a Director at Lypanosys (NZ) Ltd., Lypanosys Pte Ltd., and Kayasand Holdings Ltd.
He was formerly a Director of Business Development at Allergy Therapeutics Plc.
Turnbull received an undergraduate degree from the University of Canterbury.
Postes actifs de Andrew Peter Turnbull
| Sociétés | Poste | Début |
|---|---|---|
Lypanosys (NZ) Ltd.
 Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | 30/03/2009 |
Lypanosys Pte Ltd.
 Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Directeur/Membre du Conseil | 06/06/2011 |
Kayasand Holdings Ltd.
 Kayasand Holdings Ltd. Construction MaterialsNon-Energy Minerals Kayasand Holdings Ltd. engages in the manufacture of cement. The company was founded by Christoph Sattler on September 12, 2014 and is headquartered in Matamata, New Zealand. | Directeur/Membre du Conseil | - |
Nanolayr Ltd.
 Nanolayr Ltd. Miscellaneous Commercial ServicesCommercial Services Nanolayr Ltd. offers electrospinning proces to create custom-made nanofibre materials. The firm’s products have many applications, including filtration, cosmetics, healthcare, composites and electronics. The company was founded by Simon Vaughn Feasey, Michael John Perrett and Iain Cameron Hosie in 2009 and is headquartered in Henderson, New Zealand. | Président | 01/10/2019 |
Anciens postes connus de Andrew Peter Turnbull
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Corporate Officer/Principal | 31/12/2005 |
Formation de Andrew Peter Turnbull
| University of Canterbury | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLERGY THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Health Technology |
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
Kayasand Holdings Ltd.
Kayasand Holdings Ltd. Construction MaterialsNon-Energy Minerals Kayasand Holdings Ltd. engages in the manufacture of cement. The company was founded by Christoph Sattler on September 12, 2014 and is headquartered in Matamata, New Zealand. | Non-Energy Minerals |
Nanolayr Ltd.
Nanolayr Ltd. Miscellaneous Commercial ServicesCommercial Services Nanolayr Ltd. offers electrospinning proces to create custom-made nanofibre materials. The firm’s products have many applications, including filtration, cosmetics, healthcare, composites and electronics. The company was founded by Simon Vaughn Feasey, Michael John Perrett and Iain Cameron Hosie in 2009 and is headquartered in Henderson, New Zealand. | Commercial Services |